Hunan Zhongwei Pharmaceutical

Hunan Zhongwei Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company operates out of the Liuyang Economic and Technological Development Zone in Hunan Province, focusing primarily on antiviral, cardiovascular, and metabolic therapeutic areas. Zhongwei is notably recognized for its production of antiviral agents such as Favipiravir and treatments for chronic Hepatitis B like Entecavir. Their facilities are designed to meet international GMP standards, supporting both domestic supply and global export of high-quality pharmaceutical intermediates. The company plays a significant role in the global supply chain for essential antiviral medications.